JPRN-UMIN000033574已完成2 期
A validation study of biomarkers to predict responders to non-pharmacological multimodal program for advanced cancers - NEXTAC-Three
Department of Respirology, Kyoto Prefectual University of Medicine0 个研究点目标入组 80 人开始时间: 2019年3月31日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Having disabilities according to the modified KATZ index 2) Having high risks for safe physical assessments and interventions (e.g. Unstable cardiac diseases, Severely symptomatic brain or bone mets, severe phyciatric disease, etc) 3) Having difficulties in swallowing, digesting, and absorbing food
研究者
相似试验
已完成
不适用
Exploratory study of biomarkers predicting response to nivolumab in non-small-cell lung canceron-small-cell lung cancerJPRN-UMIN000022505Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
招募中
不适用
Biomarker studies for potentially predicting response to nivolumab in patients with unresectable or recurrent non-small cell lung cancerunresectable or recurrent non-small cell lung cancerJPRN-UMIN000026040Kagoshima University90
已完成
不适用
Investigation of biomarkers for predicting the response to steroids in patients with COPDCOPDJPRN-UMIN000010711Third Department of Internal Medicine, Wakayama Medical University80
已完成
不适用
Identification of biomarkers that predict responsiveness to Dupilumab among severe asthmaasthmaJPRN-UMIN000041915ational Hospital Organization Tokyo National Hospital15
招募中
不适用
Development of biomarker predicting the response of immunotherapy for patients with urothelial cancer using urine miRNAurothelial cancerJPRN-UMIN000047198Tokyo Medical University120